Markus Renschler - President and CEO, Director at Cyteir Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
CYT
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Markus Renschler since 12/23/2023

Holdings reported by Markus Renschler for Cyteir Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.1M $1.87M $1.69 Mar 4, 2024 Direct
Stock Option (Right to Buy) 221K Mar 4, 2024 Direct Common Stock

Transactions reported by Markus Renschler for Cyteir Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.